Back
Results - Announcements
Sales rise 4.05% to Rs 484.72 crore
Morepen Laboratories consolidated net profit declines 22.54% in the March 2026 quarter
27-May-2026, 07:35
Net profit of Morepen Laboratories declined 22.54% to Rs 15.74 crore in the quarter ended March 2026 as against Rs 20.32 crore during the previous quarter ended March 2025. Sales rose 4.05% to Rs 484.72 crore in the quarter ended March 2026 as against Rs 465.85 crore during the previous quarter ended March 2025.
Net profit of Morepen Laboratories declined 22.54% to Rs 15.74 crore in the quarter ended March 2026 as against Rs 20.32 crore during the previous quarter ended March 2025. Sales rose 4.05% to Rs 484.72 crore in the quarter ended March 2026 as against Rs 465.85 crore during the previous quarter ended March 2025.
For the full year,net profit declined 19.61% to Rs 94.88 crore in the year ended March 2026 as against Rs 118.02 crore during the previous year ended March 2025. Sales declined 0.33% to Rs 1805.69 crore in the year ended March 2026 as against Rs 1811.58 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 484.72 | 465.85 | 4 | 1805.69 | 1811.58 | 0 |
| OPM % | 5.04 | 9.07 | - | 6.96 | 9.61 | - |
| PBDT | 29.03 | 42.18 | -31 | 130.52 | 184.09 | -29 |
| PBT | 23.29 | 25.71 | -9 | 94.09 | 155.11 | -39 |
| NP | 15.74 | 20.32 | -23 | 94.88 | 118.02 | -20 |
Powered by Capital Market - Live News